Royalty Pharma (RPRX) Event July 13, 2022, 20:34 UTC (55% Positive) Royalty Pharma plc (RPRX) Announces Business Combination Full text
Register to leave comments News bot Oct. 2, 2025, 1:25 p.m. 📋 Royalty Pharma plc (RPRX) - Business Combination Filing Date: 2022-07-13 Accepted: 2022-07-13 16:34:55 Event Type: Business Combination Event Details: Royalty Pharma (RPRX) Announces Business Combination Royalty Pharma (RPRX) has entered into a strategic transaction. Transaction Details: Transaction: ROYALTY PHARMA AGREES to acquire ROYALTY INTEREST TRELEGY ELLIPTA FROM THERAVANCE INNOVIVA FORDeal Value: $1.31 million 💼 Business Developments: PartnershipAcquisitionLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: Royalty PharmaCIK: 0001802768Ticker Symbol: RPRXPeriod End Date: 2022-07-13Document Type: 8-K
📋 Royalty Pharma plc (RPRX) - Business Combination
Filing Date: 2022-07-13
Accepted: 2022-07-13 16:34:55
Event Type: Business Combination
Event Details:
💼 Business Developments:
Structured Data: